Literature DB >> 23648669

Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics.

V Grossmann, U Bacher, C Haferlach, S Schnittger, F Pötzinger, S Weissmann, A Roller, C Eder, A Fasan, M Zenger, M Staller, W Kern, A Kohlmann, T Haferlach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23648669     DOI： 10.1038/leu.2013.144

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  20 in total

1.  Clinical Characteristics and Prognosis of 167 Cases of Acute Erythroleukemia.

Authors:  Zhi-Qiang Ma; Ji-Hong Pan; Da-Xin Jing; Chong-Yan Xu
Journal:  Indian J Hematol Blood Transfus       Date:  2016-04-08       Impact factor: 0.900

2.  Molecular characterization of acute erythroid leukemia (M6-AML) using targeted next-generation sequencing.

Authors:  N Cervera; N Carbuccia; S Garnier; A Guille; J Adélaïde; A Murati; N Vey; M-J Mozziconacci; M Chaffanet; D Birnbaum; V Gelsi-Boyer
Journal:  Leukemia       Date:  2015-07-23       Impact factor: 11.528

3.  The non-erythroid myeloblast count rule in myelodysplastic syndromes: fruitful or futile?

Authors:  Margot F van Spronsen; Theresia M Westers; Birgit I Lissenberg-Witte; Mariëlle Wondergem; Gert J Ossenkoppele; Arjan A van de Loosdrecht
Journal:  Haematologica       Date:  2019-04-19       Impact factor: 9.941

4.  More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia.

Authors:  Guillermo Montalban-Bravo; Christopher B Benton; Sa A Wang; Farhad Ravandi; Tapan Kadia; Jorge Cortes; Naval Daver; Koichi Takahashi; Courtney DiNardo; Elias Jabbour; Gautam Borthakur; Marina Konopleva; Sherry Pierce; Carlos Bueso-Ramos; Keyur Patel; Steven Kornblau; Hagop Kantarjian; Ken H Young; Guillermo Garcia-Manero; Michael Andreeff
Journal:  Blood       Date:  2017-02-28       Impact factor: 22.113

5.  Genomic subtyping and therapeutic targeting of acute erythroleukemia.

Authors:  Ilaria Iacobucci; Ji Wen; Manja Meggendorfer; John K Choi; Lei Shi; Stanley B Pounds; Catherine L Carmichael; Katherine E Masih; Sarah M Morris; R Coleman Lindsley; Laura J Janke; Thomas B Alexander; Guangchun Song; Chunxu Qu; Yongjin Li; Debbie Payne-Turner; Daisuke Tomizawa; Nobutaka Kiyokawa; Marcus Valentine; Virginia Valentine; Giuseppe Basso; Franco Locatelli; Eric J Enemark; Shirley K Y Kham; Allen E J Yeoh; Xiaotu Ma; Xin Zhou; Edgar Sioson; Michael Rusch; Rhonda E Ries; Elliot Stieglitz; Stephen P Hunger; Andrew H Wei; L Bik To; Ian D Lewis; Richard J D'Andrea; Benjamin T Kile; Anna L Brown; Hamish S Scott; Christopher N Hahn; Paula Marlton; Deqing Pei; Cheng Cheng; Mignon L Loh; Benjamin L Ebert; Soheil Meshinchi; Torsten Haferlach; Charles G Mullighan
Journal:  Nat Genet       Date:  2019-03-29       Impact factor: 38.330

6.  microRNA-23a, -27a and -24 synergistically regulate JAK1/Stat3 cascade and serve as novel therapeutic targets in human acute erythroid leukemia.

Authors:  R Su; L Dong; D Zou; H Zhao; Y Ren; F Li; P Yi; L Li; Y Zhu; Y Ma; J Wang; F Wang; J Yu
Journal:  Oncogene       Date:  2016-04-18       Impact factor: 9.867

7.  De novo pure erythroid leukemia: refining the clinicopathologic and cytogenetic characteristics of a rare entity.

Authors:  Erica F Reinig; Patricia T Greipp; April Chiu; Matthew T Howard; Kaaren K Reichard
Journal:  Mod Pathol       Date:  2018-01-12       Impact factor: 7.842

8.  Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes.

Authors:  Xavier Calvo; Leonor Arenillas; Elisa Luño; Leonor Senent; Montserrat Arnan; Fernando Ramos; María Teresa Ardanaz; Carme Pedro; Mar Tormo; Julia Montoro; María Díez-Campelo; Beatriz Arrizabalaga; Blanca Xicoy; Santiago Bonanad; Andrés Jerez; Benet Nomdedeu; Ana Ferrer; Guillermo F Sanz; Lourdes Florensa
Journal:  Mod Pathol       Date:  2016-08-26       Impact factor: 7.842

9.  Acute erythroid leukemia with <20% bone marrow blasts is clinically and biologically similar to myelodysplastic syndrome with excess blasts.

Authors:  Sa A Wang; Keyur P Patel; Olga Pozdnyakova; Jie Peng; Zhuang Zuo; Paola Dal Cin; David P Steensma; Robert P Hasserjian
Journal:  Mod Pathol       Date:  2016-07-15       Impact factor: 7.842

10.  Subtype-specific patterns of molecular mutations in acute myeloid leukemia.

Authors:  D Rose; T Haferlach; S Schnittger; K Perglerová; W Kern; C Haferlach
Journal:  Leukemia       Date:  2016-06-10       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.